We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Healthwell Acquisition Corp. I (“Healthwell”) (Nasdaq: HWEL) announced today that (i) its previously announced special meeting of stockholders that was scheduled for December 4, 2023 has been...
Healthwell Acquisition Corp. I (“Healthwell”) (Nasdaq: HWEL) announced today that its previously announced Business Combination Agreement in connection with its planned business combination with...
Healthwell Acquisition Corp. I (“Healthwell,” “HWEL” or the “Company”) (NASDAQ: HWEL) announced today that it has postponed until further announcement the date of the special meeting of the...
Healthwell Acquisition Corp. I (“Healthwell,” “HWEL” or the “Company”) (NASDAQ: HWEL) announced today that it has postponed the date of the special meeting of the Company’s stockholders (the...
Dosing comes three weeks after the first site opened Full enrollment of six patients is expected to take 10 months, conducted in up to three clinical sites Multiple readings for safety and...
Gabrail Cancer & Research Center activated and open to screen patients, with Nash Gabrail, MD as lead investigator Site activation comes several months ahead of schedule, significantly...
Nash Gabrail, MD of the Gabrail Cancer Center to be lead investigator Start-up services are underway with patient enrollment planned for Q4 2023 Starton Therapeutics Inc. (“Starton” or “the...
FDA agrees to the planned Phase 1b study in second-line transplant-ineligible patients in multiple myeloma Treatment regimen will include Velcade® (bortezomib) and dexamethasone and replace oral...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0.15 | 1.45348837209 | 10.32 | 10.5 | 10.32 | 15347 | 10.40535197 | CS |
52 | 0.28 | 2.7477919529 | 10.19 | 11.8845 | 9.14 | 72020 | 10.30338072 | CS |
156 | 0.47 | 4.7 | 10 | 11.8845 | 9.14 | 45692 | 10.05755622 | CS |
260 | 0.47 | 4.7 | 10 | 11.8845 | 9.14 | 45692 | 10.05755622 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions